drugset / Trial / NCT02026011
Naltrexone for Individuals of East Asian Descent
Phase 2
Completed
87 enrolled
University of California, Los Angeles
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedCrossoverTriple-blindTreatment
Summary
This study will elucidate the pharmacogenetic effects of the Asn40Asp SNP of the OPRM1 gene on biobehavioral and neural markers of response to naltrexone in individuals of East Asian descent, an ethnic group most likely to express the positive predictive allele.
Timeline
- Start
- 2013-12
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 50 mg | — |